Aromatase inhibitors (AIs) are a class of drugs widely used in the treatment of hormone-sensitive breast cancers, particularly in postmenopausal women. They work by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens. This reduction in estrogen levels can play a crucial role in slowing down or stopping the growth of certain types of breast tumors that depend on estrogen for their development.
https://edukatorfilm.pl/2026/10/02/understanding-aromatase-inhibitors-a-comprehensive-course/
This comprehensive course on aromatase inhibitors is designed for healthcare professionals, researchers, and those interested in understanding the intricacies of AIs and their application in cancer treatment. Below are key topics covered in the course:
Enrolling in this course offers numerous benefits, including:
Aromatase inhibitors remain a critical component in the management of hormone-responsive breast cancer. This course aims to provide a well-rounded understanding of their role, benefits, and potential limitations. Whether you’re a healthcare professional looking to enhance your knowledge or a researcher wanting to delve deeper into cancer treatment, this course is an invaluable resource.

Advisory Editor: Syed Ershad Ahmed
Published by the Editor from House: 41/1, Road:1, Block:A, Niketon, Gulshan-01, Dhaka:1212, Editorial Office: House-08, Road-37, Gulshan-2,Dhaka-1212
Phone: 02-9862635, 01785902626
Email: dailyeconomistbd@gmail.com,
editordailyeconomist@gmail.com